Sign in

CIK 0001576280

  • Large accelerated filer

Guardant Health, Inc.

Sign in to watch
Ticker
GH
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
454139254
Phone
+1 855-698-8887
Business address
3100 HANOVER STREET, PALO ALTO, CA, 94304
  1. 4 Open-market sale Co-Chief Executive Officer sold 100,000 shares at an average $105.05 ($10,505,474)
  2. 4 Open-market sale Chief Information Officer sold 2,000 shares at $104.60 ($209,204)
  3. 4 Open-market sale Director sold 1,250 shares at $105.00 ($131,250)
  4. 4 Open-market sale Chief Technology Officer sold 22,935 shares at an average $105.43 ($2,417,980)
  5. 4 Open-market sale Chief Commercial Officer sold 31,452 shares at an average $103.07 ($3,241,621)
  6. 4 Open-market sale Chief Financial Officer sold 80,362 shares at an average $103.14 ($8,288,742)
  7. 4 Open-market sale Director sold 28,611 shares at an average $107.19 ($3,066,817)
  8. 4 Planned sale Chief People Officer sold 55,167 shares at an average $105.97 ($5,846,163)
  9. 4 Option exercise Director acquired 155 shares (option exercise)
  10. 4 Option exercise Director acquired 264 shares (option exercise)
  11. 4 Planned sale Director sold 116 shares at $96.25 ($11,165)
  12. 4 Option exercise Director acquired 232 shares (option exercise)
  13. 4 Option exercise Director acquired 250 shares (option exercise)
  14. 4 Open-market sale Director sold 1,500 shares at an average $95.19 ($142,780)
  15. 4 Open-market sale Chief Legal Officer sold 8,996 shares at $96.25 ($865,865)
  16. 4 Option exercise Director acquired 154 shares (option exercise)
  17. 4 Option exercise Director acquired 3,167 shares (option exercise)
  18. 4 Option exercise Director acquired 232 shares (option exercise)
  19. 4 Planned sale Director sold 116 shares at $66.95 ($7,766)
  20. 4 Planned sale Director sold 26 shares at $66.95 ($1,741)

Page 9 of 44 · 878 filings